Citations (225)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Valentina Anuta, Constantin Mircioiu, Victor Voicu, Ion Mircioiu & Roxana Sandulovici. (2021) Square root law model for the delivery and intestinal absorption of drugs: a case of hydrophilic captopril. Drug Delivery 28:1, pages 1685-1694.
Read now
Read now
Larry House, Jacqueline Ramirez, Michael Seminerio, Snezana Mirkov & Mark J. Ratain. (2015) In vitro glucuronidation of aprepitant: a moderate inhibitor of UGT2B7. Xenobiotica 45:11, pages 990-998.
Read now
Read now
Maria De Angelis, Ruggiero Francavilla, Maria Piccolo, Andrea De Giacomo & Marco Gobbetti. (2015) Autism spectrum disorders and intestinal microbiota. Gut Microbes 6:3, pages 207-213.
Read now
Read now
Omri Wolk, Riad Agbaria & Arik Dahan. (2014) Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development. Drug Design, Development and Therapy 8, pages 1563-1575.
Read now
Read now
Gudmundur Johannsson, Stanko Skrtic, Hans Lennernäs, Marcus Quinkler & Paul M. Stewart. (2014) Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments. Current Medical Research and Opinion 30:9, pages 1833-1847.
Read now
Read now
Martha Kampp N⊘hr, Sidsel Fr⊘lund, René Holm & Carsten Uhd Nielsen. (2014) Pharmacokinetic Aspects of the anti-epileptic Drug Substance vigabatrin: Focus on Transporter Interactions. Therapeutic Delivery 5:8, pages 927-942.
Read now
Read now
Kristi L Helke & Marvin Michael Swindle. (2013) Animal models of toxicology testing: the role of pigs. Expert Opinion on Drug Metabolism & Toxicology 9:2, pages 127-139.
Read now
Read now
Donna A Volpe. (2011) Drug-Permeability and Transporter Assays in Caco-2 and Mdck Cell Lines. Future Medicinal Chemistry 3:16, pages 2063-2077.
Read now
Read now
Kiyohiko Sugano. (2009) Introduction to computational oral absorption simulation. Expert Opinion on Drug Metabolism & Toxicology 5:3, pages 259-293.
Read now
Read now
Hans Lennernäs, Stanko Skrtic & Gudmundur Johannsson. (2008) Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors. Expert Opinion on Drug Metabolism & Toxicology 4:6, pages 749-758.
Read now
Read now
Articles from other publishers (215)
Stephanie Y. Zhang, Whitney S.Y. Ong, Natalia Subelzu & John P. Gleeson. (2024) Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs. International Journal of Pharmaceutics 656, pages 124089.
Crossref
Crossref
Ilaria Neri, Janis MacCallum, Ritamaria Di Lorenzo, Giacomo Russo, Frédéric Lynen & Lucia Grumetto. (2024) Into the toxicity potential of an array of parabens by biomimetic liquid chromatography, cell viability assessments and in silico predictions. Science of The Total Environment 917, pages 170461.
Crossref
Crossref
Christopher Kang, Alyson Shoji, Christophe Chipot & Rui Sun. (2024) Impact of the Unstirred Water Layer on the Permeation of Small-Molecule Drugs. Journal of Chemical Information and Modeling 64:3, pages 933-943.
Crossref
Crossref
Solene Masloh, Anne Chevrel, Maxime Culot, Anaëlle Perrocheau, Yogeshvar N. Kalia, Samuel Frehel, Rémi Gaussin, Fabien Gosselet, Simon Huet, Magali Zeisser Labouebe & Leonardo Scapozza. (2024) Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model. Pharmaceutics 16:1, pages 116.
Crossref
Crossref
So Jin Lee, Soo Hyeon Bae, Sangil Jeon, Hye Young Ji & Seunghoon Han. (2023) Combined translational pharmacometrics approach to support the design and conduct of the first‐in‐human study of DWP16001. British Journal of Clinical Pharmacology 90:1, pages 286-298.
Crossref
Crossref
Raffaella Colombo, Ilaria Frosi & Adele Papetti. 2024. Protein Digestion-Derived Peptides. Protein Digestion-Derived Peptides
1
30
.
Harshad Jadhav, Patrick Augustijns & Christer Tannergren. (2023) Approaches to Account for Colon Absorption in Physiologically Based Biopharmaceutics Modeling of Extended-Release Drug Products. Molecular Pharmaceutics 20:12, pages 6272-6288.
Crossref
Crossref
Syeda Abida Ejaz, Muhammad Sajjad Bilal, Mubashir Aziz, Tanveer A. Wani, Seema Zargar, Ammara Fayyaz, Sidra Hassan, Aftab Ahmed, Hammad M. Al Kahtani & Farhan Siddique. (2023) Computational Exploration of Fluorocyclopentenyl‐purines and‐pyrimidines Derivatives as Potential Inhibitors of Epidermal Growth Factor Receptor (EGFR) for the Treatment of Breast Cancer. Chemistry & Biodiversity 20:12.
Crossref
Crossref
Amit Kokate, Jae H. Chang & Miki S. Park. 2023. Oral Bioavailability and Drug Delivery. Oral Bioavailability and Drug Delivery
61
78
.
Li Li, Dinh Bui, Wei Zhu & Eun‐Jung (Zenobia) Jeong. 2023. Oral Bioavailability and Drug Delivery. Oral Bioavailability and Drug Delivery
801
818
.
Mirko Koziolek, Patrick Augustijns, Constantin Berger, Rodrigo Cristofoletti, David Dahlgren, Janneke Keemink, Pär Matsson, Fiona McCartney, Marco Metzger, Mario Mezler, Janis Niessen, James E. Polli, Maria Vertzoni, Werner Weitschies & Jennifer Dressman. (2023) Challenges in Permeability Assessment for Oral Drug Product Development. Pharmaceutics 15:10, pages 2397.
Crossref
Crossref
Christer Tannergren, Harshad Jadhav, Emma Eckernäs, Jonas Fagerberg, Patrick Augustijns & Erik Sjögren. (2023) Physiologically based biopharmaceutics modeling of regional and colon absorption in humans. European Journal of Pharmaceutics and Biopharmaceutics 186, pages 144-159.
Crossref
Crossref
Patricia Muschong, Liang Jin, Jan Schejbal, Mario Mezler & Manuel Weinheimer. (2023) Improvement of Workflows and Assay Reproducibility by The Introduction of “Assay-Ready” Culturing of MDCK Cells for Transport Studies. Pharmaceutical Research 40:5, pages 1259-1270.
Crossref
Crossref
Raffaella Colombo, Mayra Paolillo & Adele Papetti. (2023) A Dynamic In Vitro Model for Testing Intestinal Absorption of Different Vegetable Food Secondary Metabolites. Applied Sciences 13:8, pages 5033.
Crossref
Crossref
Min-Soo Kim, Yoo-Kyung Song, Ji-Soo Choi, Hye Young Ji, Eunsuk Yang, Joon Seok Park, Hyung Sik Kim, Min-Joo Kim, In-Kyung Cho, Suk-Jae Chung, Yoon-Jee Chae & Kyeong-Ryoon Lee. (2023) Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans. Pharmaceutics 15:3, pages 942.
Crossref
Crossref
Zitao Guo, Yuliang Yang, Bo Hu, Lingyu Zhu, Chunyu Liu, Moying Li, Zhenghua Gu, Yu Xin, Zhongpeng Guo, Haiyan Sun, Yanming Guan & Liang Zhang. (2023) The Bioaccessibility of Yak Bone Collagen Hydrolysates: Focus on Analyzing the Variation Regular of Peptides and Free Amino Acids. Foods 12:5, pages 1003.
Crossref
Crossref
Yiwen Li, Hea Jin Park, Haning Xiu, Casimir C. Akoh & Fanbin Kong. (2023) Predicting intestinal effective permeability of different transport mechanisms: Comparing ex vivo porcine and in vitro dialysis models. Journal of Food Engineering 338, pages 111256.
Crossref
Crossref
Saikat Dewanjee, Pratik Chakraborty, Abhijit Dey, Hiranmoy Bhattacharya, Chiranjib Bhattacharyya, Rupa Sanyal & Manas Bhowmik. 2023. Plant Polysaccharides as Pharmaceutical Excipients. Plant Polysaccharides as Pharmaceutical Excipients
329
368
.
Po-Chang Chiang, Jia Liu, Karthik Nagapudi, Ricky Wu, Michael Dolton, Jacob Chen, Emile Plise, Liling Liu & Matthew R. Durk. (2022) Elucidating a Potential Mechanism of Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl) amino] Caprylate in Rats: Evidence of Lymphatic Absorption of Cyanocobalamin using the Mesenteric Lymph Duct Cannulated Rat. Journal of Pharmaceutical Sciences 111:12, pages 3417-3423.
Crossref
Crossref
Dalia Safaa Hamdi & Masar Basim Mohsin Mohamed. (2022) Formulation of metoclopramide HCl gastroretentive film and in vitro- in silico prediction using Gastroplus® PBPK software. Saudi Pharmaceutical Journal 30:12, pages 1816-1824.
Crossref
Crossref
Shenghong Wang, Zhizhen Zhang, Dingsheng Li, Siena Elizabeth Illa & Li Li. (2022) In silico model-based exploration of the applicability of parallel artificial membrane permeability assay (PAMPA) to screen chemicals of environmental concern. Environment International 170, pages 107589.
Crossref
Crossref
Hanqing Liu, Wei Li, Wen Zhang, Shengrong Sun & Chuang Chen. (2022) Levothyroxine: Conventional and Novel Drug Delivery Formulations. Endocrine Reviews.
Crossref
Crossref
Asmita Adhikari, Paul R. Seo & James E. Polli. (2022) Characterization of Dissolution-Permeation System using Hollow Fiber Membrane Module and Utility to Predict in Vivo Drug Permeation Across BCS Classes. Journal of Pharmaceutical Sciences 111:11, pages 3075-3087.
Crossref
Crossref
Vanshita, Akash Garg & Hitesh Kumar Dewangan. (2022) Recent Advances in Drug Design and Delivery Across Biological Barriers
Using Computational Models. Letters in Drug Design & Discovery 19:10, pages 865-876.
Crossref
Crossref
Zhixiang Liu, Tong An, Rui Yuan, Maoxiong Tian, Linlin Yuan, Tong Zhang & Gang Cheng. (2022) Comparision of the phenol red, gravimetric, and synthesized mPEG-PR methods for correcting water flux using the single-pass intestinal perfusion method. European Journal of Pharmaceutical Sciences 176, pages 106255.
Crossref
Crossref
Gang Sheng, Na Tian, Huijuan Duan, Zhaogang Sun & Hongqian Chu. (2022) Advances in therapeutic nanodrug delivery systems for infectious lung diseases: a review. Acta Materia Medica 1:3.
Crossref
Crossref
Melissa Metry, Samuel A. Krug, Vijaya Kumari Karra, Sean Ekins, Stephen W. Hoag, Maureen A. Kane, Jeffrey C. Fink & James E. Polli. (2022) Lack of an Effect of Polysorbate 80 on Intestinal Drug Permeability in Humans. Pharmaceutical Research 39:8, pages 1881-1890.
Crossref
Crossref
Myongjae Lee, Yoo-Seong Jeong, Min-Soo Kim, Kyung-Mi An & Suk-Jae Chung. (2022) Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics. Pharmaceutics 14:6, pages 1157.
Crossref
Crossref
Donato Teutonico, Michael Block, Lars Kuepfer, Juri Solodenko, Thomas Eissing & Katrin Coboeken. 2022. Oral Drug Delivery for Modified Release Formulations. Oral Drug Delivery for Modified Release Formulations
375
389
.
Joseph P. O'Shea, Patrick Augustijns, Martin Brandl, David J. Brayden, Joachim Brouwers, Brendan T. Griffin, René Holm, Ann-Christin Jacobsen, Hans Lennernäs, Zahari Vinarov & Caitriona M. O'Driscoll. (2022) Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review. European Journal of Pharmaceutical Sciences 170, pages 106098.
Crossref
Crossref
Alyson Shoji, Christopher Kang, Kazuumi Fujioka, John P. Rose & Rui Sun. (2021) Assessing the Intestinal Permeability of Small Molecule Drugs via Diffusion Motion on a Multidimensional Free Energy Surface. Journal of Chemical Theory and Computation 18:1, pages 503-515.
Crossref
Crossref
David Dahlgren & Hans Lennernäs. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
406
437
.
Alan Talevi & Carolina L. Bellera. 2022. The ADME Encyclopedia. The ADME Encyclopedia
558
566
.
Alan Talevi & Carolina L. Bellera. 2022. The ADME Encyclopedia. The ADME Encyclopedia
786
792
.
Emma L. Betts, Jamie M. Newton, Gary S. Thompson, Fakhriddin Sarzhanov, Vasana Jinatham, Moon-Ju Kim, Siam Popluechai, Funda Dogruman-Al, Eun-Jeong Won, Eleni Gentekaki & Anastasios D. Tsaousis. (2021) Metabolic Fluctuations in the Human Stool Obtained from Blastocystis Carriers and Non-Carriers. Metabolites 11:12, pages 883.
Crossref
Crossref
Quchat Shekarri & Matthijs Dekker. (2021) A Physiological-Based Model for Simulating the Bioavailability and Kinetics of Sulforaphane from Broccoli Products. Foods 10:11, pages 2761.
Crossref
Crossref
Takato Masada, Toshihide Takagi, Keiko Minami, Makoto Kataoka, Shoko Takeyama, Yoshimine Fujii, Masayuki Takahashi & Shinji Yamashita. (2021) New biphasic system in side-by-side chambers for testing drug dissolution and permeation in vitro (BiDP system). Journal of Drug Delivery Science and Technology 65, pages 102747.
Crossref
Crossref
Edward Price, J. Cory Kalvass, David DeGoey, Balakrishna Hosmane, Stella Doktor & Kelly Desino. (2021)
Global Analysis of Models for Predicting Human Absorption: QSAR,
In Vitro
, and Preclinical Models
. Journal of Medicinal Chemistry 64:13, pages 9389-9403.
Crossref
Crossref
Karline C. Rodrigues, Cristiani F. Bortolatto, Ketlyn P. da Motta, Renata L. de Oliveira, Jaini J. Paltian, Roberta Krüger, Silvane S. Roman, Silvana P. Boeira, Diego Alves, Ethel Antunes Wilhelm & Cristiane Luchese. (2021) The neurotherapeutic role of a selenium-functionalized quinoline in hypothalamic obese rats. Psychopharmacology 238:7, pages 1937-1951.
Crossref
Crossref
Donglu Zhang, Cong WeiCornelis E. C. A. HopMatthew R. WrightMing HuYurong Lai, S. Cyrus KhojastehW. Griff Humphreys. (2021) Intestinal Excretion, Intestinal Recirculation, and Renal Tubule Reabsorption Are Underappreciated Mechanisms That Drive the Distribution and Pharmacokinetic Behavior of Small Molecule Drugs. Journal of Medicinal Chemistry 64:11, pages 7045-7059.
Crossref
Crossref
Fumihiko Igarashi, Toshito Nakagawa, Yuka Shinohara & Tatsuhiko Tachibana. (2021) Analysis of Non-linear Pharmacokinetics of P-Glycoprotein Substrates in a Microfluidic Device Using a Mathematical Model that Includes an Unstirred Water Layer (UWL) Compartment. Pharmaceutical Research 38:6, pages 1031-1039.
Crossref
Crossref
Anallely López-Yerena, Maria Pérez, Anna Vallverdú-Queralt, Eleftherios Miliarakis, Rosa M. Lamuela-Raventós & Elvira Escribano-Ferrer. (2021) Oleacein Intestinal Permeation and Metabolism in Rats Using an In Situ Perfusion Technique. Pharmaceutics 13:5, pages 719.
Crossref
Crossref
Emma Eckernäs & Christer Tannergren. (2021) Physiologically Based Biopharmaceutics Modeling of Regional and Colon Absorption in Dogs. Molecular Pharmaceutics 18:4, pages 1699-1710.
Crossref
Crossref
Feifan Xie, Jan Van Bocxlaer & An Vermeulen. (2020) Physiologically based pharmacokinetic modelling of lisinopril in children: A case story of angiotensin converting enzyme inhibitors. British Journal of Clinical Pharmacology 87:3, pages 1203-1214.
Crossref
Crossref
Mohammed S. Alqahtani, Mohsin Kazi, Mohammad A. Alsenaidy & Muhammad Z. Ahmad. (2021) Advances in Oral Drug Delivery. Frontiers in Pharmacology 12.
Crossref
Crossref
Laura Maria Fuhr, Fatima Zahra Marok, Nina Hanke, Dominik Selzer & Thorsten Lehr. (2021) Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug–Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach. Pharmaceutics 13:2, pages 270.
Crossref
Crossref
Xavier J.H. Pepin, Jennifer Dressman, Neil Parrott, Poonam Delvadia, Amitava Mitra, Xinyuan Zhang, Andrew Babiskin, Vidula Kolhatkar, Paul Seo, Lynne S. Taylor, Erik Sjögren, James M. Butler, Edmund Kostewicz, Christer Tannergren, Mirko Koziolek, Filippos Kesisoglou, André Dallmann, Yang Zhao & Sandra Suarez-Sharp. (2021) In Vitro Biopredictive Methods: A Workshop Summary Report. Journal of Pharmaceutical Sciences 110:2, pages 567-583.
Crossref
Crossref
Jens A. Poulsen, Christer Tannergren, Anders Borde, Jan Westergren & Lennart Lindfors. 2021. Systems Medicine. Systems Medicine
223
231
.
Alan Talevi & Carolina L. Bellera. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
9
.
Alan Talevi & Carolina L. Bellera. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
8
.
Jerome Hochman, Tomi Sawyer & Ruchia Duggal. 2021. Quantitative Analysis of Cellular Drug Transport, Disposition, and Delivery. Quantitative Analysis of Cellular Drug Transport, Disposition, and Delivery
201
227
.
Susan A. Charman, Alice Andreu, Helena Barker, Scott Blundell, Anna Campbell, Michael Campbell, Gong Chen, Francis C. K. Chiu, Elly Crighton, Kasiram Katneni, Julia Morizzi, Rahul Patil, Thao Pham, Eileen Ryan, Jessica Saunders, David M. Shackleford, Karen L. White, Lisa Almond, Maurice Dickins, Dennis A. Smith, Joerg J. Moehrle, Jeremy N. Burrows & Nada Abla. (2020) An in vitro toolbox to accelerate anti-malarial drug discovery and development. Malaria Journal 19:1.
Crossref
Crossref
Guo Chen, Xingqi Min, Qunqun Zhang, Zhiqiang Zhang, Meiqiang Wen, Jun Yang, Meijuan Zou, Wei Sun & Gang Cheng. (2020) Synthesis and Evaluation of PEG-PR for Water Flux Correction in an In Situ Rat Perfusion Model. Molecules 25:21, pages 5123.
Crossref
Crossref
Sarinj Fattah, Mohamed Ismaiel, Brenda Murphy, Aleksandra Rulikowska, Jesus M. Frias, Desmond C. Winter & David J. Brayden. (2020) Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers. European Journal of Pharmaceutical Sciences 154, pages 105509.
Crossref
Crossref
Johanna Eriksson, Helena Thörn, Hans Lennernäs & Erik Sjögren. (2020) Pulmonary drug absorption and systemic exposure in human: Predictions using physiologically based biopharmaceutics modeling. European Journal of Pharmaceutics and Biopharmaceutics 156, pages 191-202.
Crossref
Crossref
Alexandro Barbosa de Souza, Marco Vinícius Chaud, Thais Francine Alves, Juliana Ferreira de Souza & Maria Andrade Santana. (2020) Hyaluronic Acid in the Intestinal Tract: Influence of Structure, Rheology, and Mucoadhesion on the Intestinal Uptake in Rats. Biomolecules 10:10, pages 1422.
Crossref
Crossref
Hiroaki Yuasa, Tomoya Yasujima & Katsuhisa Inoue. (2020) Current Understanding of the Intestinal Absorption of Nucleobases and Analogs. Biological and Pharmaceutical Bulletin 43:9, pages 1293-1300.
Crossref
Crossref
Naseem A. Charoo, Daud B. Abdallah, Thahera Parveen, Bertil Abrahamsson, Rodrigo Cristofoletti, Dirk W. Groot, Peter Langguth, Alan Parr, James E. Polli, Mehul Mehta, Vinod P. Shah, Tomokazu Tajiri & Jennifer Dressman. (2020) Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Moxifloxacin Hydrochloride. Journal of Pharmaceutical Sciences 109:9, pages 2654-2675.
Crossref
Crossref
Bastian Haering, Stefan Seyferth & Heiko A. Schiffter. (2020) The tangential flow absorption model (TFAM) – A novel dissolution method for evaluating the performance of amorphous solid dispersions of poorly water-soluble actives. European Journal of Pharmaceutics and Biopharmaceutics 154, pages 74-88.
Crossref
Crossref
Martin A. Hofsäss & Jennifer Dressman. (2020) Evaluation of Differences in Dosage Form Performance of Generics Using BCS-Based Biowaiver Specifications and Biopharmaceutical Modeling–Case Examples Amoxicillin and Doxycycline. Journal of Pharmaceutical Sciences 109:8, pages 2437-2453.
Crossref
Crossref
Po-Chang Chiang, Karthik Nagapudi, Michael J. Dolton & Jia Liu. (2020) Exploring Multicompartment Plug Flow–Based Model Approach in Biopharmaceutics: Impact of Stomach Setting and the Estimation of the Fraction Absorbed of Orally Administered Basic Drugs. Journal of Pharmaceutical Sciences 109:3, pages 1261-1269.
Crossref
Crossref
Biljana Gatarić & Jelena Parojčić. (2019) An Investigation into the Factors Governing Drug Absorption and Food Effect Prediction Based on Data Mining Methodology. The AAPS Journal 22:1.
Crossref
Crossref
Henry P. Diehl, Aldyn Wildey, Vivitri D. Prasasty & Teruna J. Siahaan. 2020. Nanotechnology for Oral Drug Delivery. Nanotechnology for Oral Drug Delivery
7
25
.
Maiara Camotti Montanha, Andréa Diniz, Nuno Miguel Elvas Neves Silva, Elza Kimura & Paulo Paixão. (2019) Physiologically-Based Pharmacokinetic Model on the Oral Drug Absorption in Roux-en-Y Gastric Bypass Bariatric Patients: Amoxicillin Tablet and Suspension. Molecular Pharmaceutics 16:12, pages 5025-5034.
Crossref
Crossref
Nidhi Nainwal, Ranjit Singh, Sunil Jawla & Vikas Anand Saharan. (2019) The Solubility-Permeability Interplay for Solubility-Enabling Oral Formulations. Current Drug Targets 20:14, pages 1434-1446.
Crossref
Crossref
Biying Zhang, Yawen Lu, Ping Li, Xiaodong Wen & Jie Yang. (2019) Study on the absorption of corosolic acid in the gastrointestinal tract and its metabolites in rats. Toxicology and Applied Pharmacology 378, pages 114600.
Crossref
Crossref
D. Dahlgren, M. Sjöblom & H. Lennernäs. (2019) Intestinal absorption-modifying excipients: A current update on preclinical in vivo evaluations. European Journal of Pharmaceutics and Biopharmaceutics 142, pages 411-420.
Crossref
Crossref
C. Roos, D. Dahlgren, E. Sjögren, M. Sjöblom, M. Hedeland & H. Lennernäs. (2019) Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions. European Journal of Pharmaceutics and Biopharmaceutics 142, pages 387-395.
Crossref
Crossref
Xavier J.H. Pepin, Andrea J. Moir, James C. Mann, Natalie J. Sanderson, Richard Barker, Elizabeth Meehan, Allan P. Plumb, George R. Bailey, Dean S. Murphy, Cecile M. Krejsa, Marilee A. Andrew, Timothy G. Ingallinera & J. Greg Slatter. (2019) Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part II. A mechanistic PBPK model for IR formulation comparison, proton pump inhibitor drug interactions, and administration with acidic juices. European Journal of Pharmaceutics and Biopharmaceutics 142, pages 435-448.
Crossref
Crossref
D. Dahlgren, C. Roos, K. Peters, A. Lundqvist, C. Tannergren, E. Sjögren, M. Sjöblom & H. Lennernäs. (2019) Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model. European Journal of Pharmaceutics and Biopharmaceutics 142, pages 31-37.
Crossref
Crossref
David Dahlgren & Hans Lennernäs. (2019) Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches. Pharmaceutics 11:8, pages 411.
Crossref
Crossref
Raffaella Colombo, Mayra Paolillo & Adele Papetti. (2019) A new millifluidic-based gastrointestinal platform to evaluate the effect of simulated dietary methylglyoxal intakes. Food & Function 10:7, pages 4330-4338.
Crossref
Crossref
Qingbiao Xu, Hui Hong, Jianping Wu & Xianghua Yan. (2019) Bioavailability of bioactive peptides derived from food proteins across the intestinal epithelial membrane: A review. Trends in Food Science & Technology 86, pages 399-411.
Crossref
Crossref
Julian Rosenberger, James Butler, Uwe Muenster & Jennifer Dressman. (2019) Application of a Refined Developability Classification System. Journal of Pharmaceutical Sciences 108:3, pages 1090-1100.
Crossref
Crossref
Han Xing, Chang Ren, Ying Kong, Chen Ning, Dexuan Kong, Yongjie Zhang, Di Zhao, Ning Li, Zeyu Wang, Xijing Chen & Yang Lu. (2019) Mechanistic study of absorption and first‐pass metabolism of GL‐V9, a derivative of wogonin. Biopharmaceutics & Drug Disposition 40:3-4, pages 151-161.
Crossref
Crossref
Camilla Virili, Alessandro Antonelli, Maria Giulia Santaguida, Salvatore Benvenga & Marco Centanni. (2019) Gastrointestinal Malabsorption of Thyroxine. Endocrine Reviews 40:1, pages 118-136.
Crossref
Crossref
Biljana Gatarić & Jelena Parojčić. (2019) Application of data mining approach to identify drug subclasses based on solubility and permeability. Biopharmaceutics & Drug Disposition 40:2, pages 51-61.
Crossref
Crossref
Yi-ting Zhang, Yu-qi Yu, Xiao-xia Yan, Wen-jie Wang, Xiao-ting Tian, Le Wang, Wei-liang Zhu, Li-kun Gong & Guo-yu Pan. (2018) Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity. Acta Pharmacologica Sinica 40:1, pages 133-142.
Crossref
Crossref
Omri Wolk, Milica Markovic, Daniel Porat, Noa Fine-Shamir, Moran Zur, Avital Beig & Arik Dahan. (2019) Segmental-Dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In Vivo Permeability Values. Journal of Pharmaceutical Sciences 108:1, pages 316-325.
Crossref
Crossref
Alina Strugari, Miruna Stan, Sami Gharbia, Anca Hermenean & Anca Dinischiotu. (2018) Characterization of Nanoparticle Intestinal Transport Using an In Vitro Co-Culture Model. Nanomaterials 9:1, pages 5.
Crossref
Crossref
Maria Vertzoni, Elisabeth Kersten, Dorina van der Mey, Uwe Muenster & Christos Reppas. (2018) Evaluating the clinical importance of bacterial degradation of therapeutic agents in the lower intestine of adults using adult fecal material. European Journal of Pharmaceutical Sciences 125, pages 142-150.
Crossref
Crossref
C. Roos, J. Westergren, D. Dahlgren, H. Lennernäs & E. Sjögren. (2018) Mechanistic modelling of intestinal drug absorption – The in vivo effects of nanoparticles, hydrodynamics, and colloidal structures. European Journal of Pharmaceutics and Biopharmaceutics 133, pages 70-76.
Crossref
Crossref
Eugene C. Chen, Fabio Broccatelli, Emile Plise, Buyun Chen, Liling Liu, Jonathan Cheong, Shu Zhang, Jamie Jorski, Katherine Gaffney, Kayla K. Umemoto & Laurent Salphati. (2018) Evaluating the Utility of Canine Mdr1 Knockout Madin-Darby Canine Kidney I Cells in Permeability Screening and Efflux Substrate Determination. Molecular Pharmaceutics 15:11, pages 5103-5113.
Crossref
Crossref
D. Dahlgren, C. Roos, A. Lundqvist, C. Tannergren, M. Sjöblom, E. Sjögren & H. Lennernäs. (2018) Time-dependent effects on small intestinal transport by absorption-modifying excipients. European Journal of Pharmaceutics and Biopharmaceutics 132, pages 19-28.
Crossref
Crossref
Kasiram Katneni, Thao Pham, Jessica Saunders, Gong Chen, Rahul Patil, Karen L. White, Nada Abla, Francis C. K. Chiu, David M. Shackleford & Susan A. Charman. (2018) Using Human Plasma as an Assay Medium in Caco-2 Studies Improves Mass Balance for Lipophilic Compounds. Pharmaceutical Research 35:11.
Crossref
Crossref
D. Dahlgren, C. Roos, A. Lundqvist, C. Tannergren, M. Sjöblom, E. Sjögren & H. Lennernäs. (2018) Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport. International Journal of Pharmaceutics 549:1-2, pages 239-248.
Crossref
Crossref
Avital Beig, Milica Markovic & Arik Dahan. 2018. Early Drug Development. Early Drug Development
171
202
.
D. Dahlgren, C. Roos, P. Johansson, C. Tannergren, A. Lundqvist, P. Langguth, M. Sjöblom, E. Sjögren & H. Lennernäs. (2018) The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs. International Journal of Pharmaceutics 547:1-2, pages 158-168.
Crossref
Crossref
Po-Chang Chiang, Jia Liu, Peter Fan & Harvey Wong. (2018) Exploring a Kinetic Model Approach in Biopharmaceutics: Estimating the Fraction Absorbed of Orally Administered Drugs in Humans. Journal of Pharmaceutical Sciences 107:7, pages 1798-1805.
Crossref
Crossref
Miguel Ángel Cabrera‐Pérez, Hai Pham‐The, Mirna Fernández Cervera, Rosario Hernández‐Armengol, Claudia Miranda‐Pérez de Alejo & Yudileidy Brito‐Ferrer. (2018) Integrating theoretical and experimental permeability estimations for provisional biopharmaceutical classification: Application to the WHO essential medicines. Biopharmaceutics & Drug Disposition 39:7, pages 354-368.
Crossref
Crossref
Angus R. Hibbins, Mershen Govender, Sunaina Indermun, Pradeep Kumar, Lisa C. du Toit, Yahya E. Choonara & Viness Pillay. (2018) In Vitro–In Vivo Evaluation of an Oral Ghost Drug Delivery Device for the Delivery of Salmon Calcitonin. Journal of Pharmaceutical Sciences 107:6, pages 1605-1614.
Crossref
Crossref
Ditlev Birch, Ragna G. Diedrichsen, Philip C. Christophersen, Huiling Mu & Hanne M. Nielsen. (2018) Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium. European Journal of Pharmaceutical Sciences 118, pages 144-153.
Crossref
Crossref
Johanna Eriksson, Erik Sjögren, Helena Thörn, Katarina Rubin, Per Bäckman & Hans Lennernäs. (2018) Pulmonary absorption – estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis. European Journal of Pharmaceutics and Biopharmaceutics 124, pages 1-12.
Crossref
Crossref
R. G. Lentle. (2018) Deconstructing the physical processes of digestion: reductionist approaches may provide greater understanding. Food & Function 9:8, pages 4069-4084.
Crossref
Crossref
Isabel Lozoya-Agullo, Isabel Gonzalez-Alvarez, Moran Zur, Noa Fine-Shamir, Yael Cohen, Milica Markovic, Teresa M. Garrigues, Arik Dahan, Marta Gonzalez-Alvarez, Matilde Merino-Sanjuán, Marival Bermejo & Alex Avdeef. (2017) Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat—Biophysical Model and Predictions Based on Caco-2. Pharmaceutical Research 35:1.
Crossref
Crossref
David Dahlgren, Carl Roos, Anders Lundqvist, Christer Tannergren, Peter Langguth, Markus Sjöblom, Erik Sjögren & Hans Lennernäs. (2017)
Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker
51
Cr-EDTA
. Molecular Pharmaceutics 14:12, pages 4243-4251.
Crossref
Crossref
Carl Roos, David Dahlgren, Erik Sjögren, Christer Tannergren, Bertil Abrahamsson & Hans Lennernäs. (2017) Regional Intestinal Permeability in Rats: A Comparison of Methods. Molecular Pharmaceutics 14:12, pages 4252-4261.
Crossref
Crossref
Alejandro Ruiz-Picazo, Isabel Lozoya-Agullo, Miguel Ortiz-Azcarate, Matilde Merino-Sanjuán, Marta González-Álvarez, Isabel González-Álvarez & Marival Bermejo. (2017) Comparison of segmental-dependent permeability in human and in situ perfusion model in rat. European Journal of Pharmaceutical Sciences 107, pages 191-196.
Crossref
Crossref
Dongyang Liu, Yi Zhang, Ji Jiang, John Choi, Xuening Li, Dalong Zhu, Dawei Xiao, Yanhua Ding, Hongwei Fan, Li Chen & Pei Hu. (2016) Translational Modeling and Simulation in Supporting Early-Phase Clinical Development of New Drug: A Learn–Research–Confirm Process. Clinical Pharmacokinetics 56:8, pages 925-939.
Crossref
Crossref
Le Sun, Jin Sun & Zhonggui He. (2016) Exploring the Feasibility of Biowaiver Extension of BCS Class III Drugs with Site-Specific Absorption Using Gastrointestinal Simulation Technology. European Journal of Drug Metabolism and Pharmacokinetics 42:3, pages 471-487.
Crossref
Crossref
Assmaa O. Selim, Zienab A. Gouda & Sally A. Selim. (2017) An experimental study of a rat model of emphysema induced by cigarette smoke exposure and the effect of Survanta therapy. Annals of Anatomy - Anatomischer Anzeiger 211, pages 69-77.
Crossref
Crossref
B.F. Thomazini & M.A.H. Dolder. (2017) Dose dependent treatment with isotretinoin induces more changes in the ileum than in the duodenum and jejunum in Wistar rats. Tissue and Cell 49:2, pages 203-208.
Crossref
Crossref
Luai Al Rabadi & Raymond Bergan. (2017) A Way Forward for Cancer Chemoprevention: Think Local. Cancer Prevention Research 10:1, pages 14-35.
Crossref
Crossref
Vladimir I. Razinkov & Gerd R. Kleemann. 2017. High-Throughput Formulation Development of Biopharmaceuticals. High-Throughput Formulation Development of Biopharmaceuticals
11
43
.
Chie EmotoAlexander A. VinksTsuyoshi Fukuda. (2016) Risk Assessment of Drug–Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant Patients. Therapeutic Drug Monitoring 38:5, pages 607-613.
Crossref
Crossref
Peng Zhang, Teresa Zardán Gómez de la Torre, Ken Welch, Christel Bergström & Maria Strømme. (2016) Supersaturation of poorly soluble drugs induced by mesoporous magnesium carbonate. European Journal of Pharmaceutical Sciences 93, pages 468-474.
Crossref
Crossref
L Kuepfer, C Niederalt, T Wendl, J‐F Schlender, S Willmann, J Lippert, M Block, T Eissing & D Teutonico. (2016) Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model. CPT: Pharmacometrics & Systems Pharmacology 5:10, pages 516-531.
Crossref
Crossref
David Dahlgren, Carl Roos, Pernilla Johansson, Anders Lundqvist, Christer Tannergren, Bertil Abrahamsson, Erik Sjögren & Hans Lennernäs. (2016) Regional Intestinal Permeability in Dogs: Biopharmaceutical Aspects for Development of Oral Modified-Release Dosage Forms. Molecular Pharmaceutics 13:9, pages 3022-3033.
Crossref
Crossref
David Dahlgren, Carl Roos, Anders Lundqvist, Bertil Abrahamsson, Christer Tannergren, Per M. Hellström, Erik Sjögren & Hans Lennernäs. (2016) Regional Intestinal Permeability of Three Model Drugs in Human. Molecular Pharmaceutics 13:9, pages 3013-3021.
Crossref
Crossref
Erik Sjögren, Helena Thörn & Christer Tannergren. (2016)
In Silico
Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models
. Molecular Pharmaceutics 13:6, pages 1763-1778.
Crossref
Crossref
Kristi L. Helke, Keith N. Nelson, Aaron M. Sargeant, Binod Jacob, Sean McKeag, Julius Haruna, Vimala Vemireddi, Melanie Greeley, Derek Brocksmith, Nicole Navratil, Alain Stricker-Krongrad & Charlotte Hollinger. (2016) Pigs in Toxicology. Toxicologic Pathology 44:4, pages 575-590.
Crossref
Crossref
Stefanie D. Krämer. (2016) Quantitative aspects of drug permeation across in vitro and in vivo barriers. European Journal of Pharmaceutical Sciences 87, pages 30-46.
Crossref
Crossref
Brahma N. Singh. 2015. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials
2782
2811
.
Jia He, Michael H. Abraham, William E. AcreeJr.Jr. & Yuan H. Zhao. (2015) A linear free energy analysis of PAMPA models for biological systems. International Journal of Pharmaceutics 496:2, pages 717-722.
Crossref
Crossref
Cuyue Tang, Jerome Hochman & Thomayant Prueksaritanont. 2015. New Horizons in Predictive Drug Metabolism and Pharmacokinetics. New Horizons in Predictive Drug Metabolism and Pharmacokinetics
263
282
.
Andrés Olivares-Morales, Hans Lennernäs, Leon Aarons & Amin Rostami-Hodjegan. (2015) Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug Absorption. The AAPS Journal 17:5, pages 1177-1192.
Crossref
Crossref
David Dahlgren, Carl Roos, Erik Sjögren & Hans Lennernäs. (2015) Direct In Vivo Human Intestinal Permeability (Peff) Determined with Different Clinical Perfusion and Intubation Methods. Journal of Pharmaceutical Sciences 104:9, pages 2702-2726.
Crossref
Crossref
Mary S. Kleppe, Kelly M. Forney-Stevens, Roy J. Haskell & Robin H. Bogner. (2015) Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs. The AAPS Journal 17:4, pages 902-917.
Crossref
Crossref
Moran Zur, Noa Cohen, Riad Agbaria & Arik Dahan. (2015) The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract. International Journal of Pharmaceutics 489:1-2, pages 304-310.
Crossref
Crossref
Raj K. Singh Badhan. 2015. Computational Pharmaceutics. Computational Pharmaceutics
263
291
.
Erik Sjögren, David Dahlgren, Carl Roos & Hans Lennernäs. (2015)
Human
in Vivo
Regional Intestinal Permeability: Quantitation Using Site-Specific Drug Absorption Data
. Molecular Pharmaceutics 12:6, pages 2026-2039.
Crossref
Crossref
Isabel Lozoya-Agullo, Moran Zur, Omri Wolk, Avital Beig, Isabel González-Álvarez, Marta González-Álvarez, Matilde Merino-Sanjuán, Marival Bermejo & Arik Dahan. (2015) In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches. International Journal of Pharmaceutics 480:1-2, pages 1-7.
Crossref
Crossref
Jerome Hochman, Cuyue Tang & Thomayant Prueksaritanont. (2015) Drug–Drug Interactions Related to Altered Absorption and Plasma Protein Binding: Theoretical and Regulatory Considerations, and an Industry Perspective. Journal of Pharmaceutical Sciences 104:3, pages 916-929.
Crossref
Crossref
Benjamin Wuyts, Danny Riethorst, Joachim Brouwers, Jan Tack, Pieter Annaert & Patrick Augustijns. (2015) Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system in the Ussing chambers model to explore food effects on intestinal permeability. International Journal of Pharmaceutics 478:2, pages 736-744.
Crossref
Crossref
Benjamin Wuyts, Danny Riethorst, Joachim Brouwers, Jan Tack, Pieter Annaert & Patrick Augustijns. (2015) Evaluation of fasted state human intestinal fluid as apical solvent system in the Caco-2 absorption model and comparison with FaSSIF. European Journal of Pharmaceutical Sciences 67, pages 126-135.
Crossref
Crossref
Andrés Olivares-Morales, Yoshiteru Kamiyama, Adam S. Darwich, Leon Aarons & Amin Rostami-Hodjegan. (2015) Analysis of the impact of controlled release formulations on oral drug absorption, gut wall metabolism and relative bioavailability of CYP3A substrates using a physiologically-based pharmacokinetic model. European Journal of Pharmaceutical Sciences 67, pages 32-44.
Crossref
Crossref
Salvador Marí-Bauset, Itziar Zazpe, Amelia Mari-Sanchis, Agustín Llopis-González & María Morales-Suárez-Varela. (2014) Evidence of the Gluten-Free and Casein-Free Diet in Autism Spectrum Disorders. Journal of Child Neurology 29:12, pages 1718-1727.
Crossref
Crossref
Warren M. Miner-Williams, Bruce R. Stevens & Paul J. Moughan. (2015) Are intact peptides absorbed from the healthy gut in the adult human?. Nutrition Research Reviews 27:2, pages 308-329.
Crossref
Crossref
Natsuki Kogure, Takeshi Akiyoshi, Ayuko Imaoka & Hisakazu Ohtani. (2014) Prediction of the extent and variation of grapefruit juice–drug interactions from the pharmacokinetic profile in the absence of grapefruit juice. Biopharmaceutics & Drug Disposition 35:7, pages 373-381.
Crossref
Crossref
Samir Mitragotri, Paul A. Burke & Robert Langer. (2014) Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nature Reviews Drug Discovery 13:9, pages 655-672.
Crossref
Crossref
Moran Zur, Allison S. Hanson & Arik Dahan. (2014) The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation. European Journal of Pharmaceutical Sciences 61, pages 11-17.
Crossref
Crossref
Serena Giusti, Tommaso Sbrana, Margherita La Marca, Valentina Di Patria, Valentina Martinucci, Annalisa Tirella, Claudio Domenici & Arti Ahluwalia. (2014) A novel dual‐flow bioreactor simulates increased fluorescein permeability in epithelial tissue barriers. Biotechnology Journal 9:9, pages 1175-1184.
Crossref
Crossref
Michael H. Abraham. (2014) Human Intestinal Absorption—Neutral Molecules and Ionic Species. Journal of Pharmaceutical Sciences 103:7, pages 1956-1966.
Crossref
Crossref
Erik Sjögren, Bertil Abrahamsson, Patrick Augustijns, Dieter Becker, Michael B. Bolger, Marcus Brewster, Joachim Brouwers, Talia Flanagan, Matthew Harwood, Christian Heinen, René Holm, Hans-Paul Juretschke, Marlies Kubbinga, Anders Lindahl, Viera Lukacova, Uwe Münster, Sibylle Neuhoff, Mai Anh Nguyen, Achiel van Peer, Christos Reppas, Amin Rostami Hodjegan, Christer Tannergren, Werner Weitschies, Clive Wilson, Patricia Zane, Hans Lennernäs & Peter Langguth. (2014) In vivo methods for drug absorption – Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects. European Journal of Pharmaceutical Sciences 57, pages 99-151.
Crossref
Crossref
Edmund S. Kostewicz, Leon Aarons, Martin Bergstrand, Michael B. Bolger, Aleksandra Galetin, Oliver Hatley, Masoud Jamei, Richard Lloyd, Xavier Pepin, Amin Rostami-Hodjegan, Erik Sjögren, Christer Tannergren, David B. Turner, Christian Wagner, Werner Weitschies & Jennifer Dressman. (2014) PBPK models for the prediction of in vivo performance of oral dosage forms. European Journal of Pharmaceutical Sciences 57, pages 300-321.
Crossref
Crossref
Hans Lennernäs. (2014) Regional intestinal drug permeation: Biopharmaceutics and drug development. European Journal of Pharmaceutical Sciences 57, pages 333-341.
Crossref
Crossref
Hannah K. Batchelor, Nikoletta Fotaki & Sandra Klein. (2014) Paediatric oral biopharmaceutics: Key considerations and current challenges. Advanced Drug Delivery Reviews 73, pages 102-126.
Crossref
Crossref
Caroline A. Larregieu & Leslie Z. Benet. (2014) Distinguishing between the Permeability Relationships with Absorption and Metabolism To Improve BCS and BDDCS Predictions in Early Drug Discovery. Molecular Pharmaceutics 11:4, pages 1335-1344.
Crossref
Crossref
Donna A. Volpe, Hong Shen & Praveen V. Balimane. 2014. Predictive ADMET. Predictive ADMET
263
290
.
Sara Carlert, Hans Lennernäs & Bertil Abrahamsson. (2014) Evaluation of the use of Classical Nucleation Theory for predicting intestinal crystalline precipitation of two weakly basic BSC class II drugs. European Journal of Pharmaceutical Sciences 53, pages 17-27.
Crossref
Crossref
Hans Lennernäs. (2013)
Human
in Vivo
Regional Intestinal Permeability: Importance for Pharmaceutical Drug Development
. Molecular Pharmaceutics 11:1, pages 12-23.
Crossref
Crossref
Aleksandra Galetin. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
255
288
.
Omri Wolk & Arik Dahan. 2014. Focal Controlled Drug Delivery. Focal Controlled Drug Delivery
343
357
.
David G Levitt. (2013) Quantitation of small intestinal permeability during normal human drug absorption. BMC Pharmacology and Toxicology 14:1.
Crossref
Crossref
Arik Dahan, Omri Wolk, Young Hoon Kim, Chandrasekharan Ramachandran, Gordon M. Crippen, Toshihide Takagi, Marival Bermejo & Gordon L. Amidon. (2013) Purely in Silico BCS Classification: Science Based Quality Standards for the World’s Drugs. Molecular Pharmaceutics 10:11, pages 4378-4390.
Crossref
Crossref
Salvador Marí Bauset, Itziar Zazpe, Amelia Marí Sanchis, Agustín Llopis González & María Morales Suárez-Varela. (2012) Are There Anthropometric Differences Between Autistic and Healthy Children?. Journal of Child Neurology 28:10, pages 1226-1232.
Crossref
Crossref
Le Sun, Xiaohong Liu, Rongwu Xiang, Chunnuan Wu, Yongjun Wang, Yinghua Sun, Jin Sun & Zhonggui He. (2013)
Structure‐based prediction of human intestinal membrane permeability for rapid
in silico
BCS classification
. Biopharmaceutics & Drug Disposition 34:6, pages 321-335.
Crossref
Crossref
Erik Sjögren, Jan Westergren, Iain Grant, Gunilla Hanisch, Lennart Lindfors, Hans Lennernäs, Bertil Abrahamsson & Christer Tannergren. (2013) In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: Application of the mechanistic absorption model GI-Sim. European Journal of Pharmaceutical Sciences 49:4, pages 679-698.
Crossref
Crossref
Moran Fairstein, Rotem Swissa & Arik Dahan. (2013) Regional-Dependent Intestinal Permeability and BCS Classification: Elucidation of pH-Related Complexity in Rats Using Pseudoephedrine. The AAPS Journal 15:2, pages 589-597.
Crossref
Crossref
Caroline A. Larregieu & Leslie Z. Benet. (2013) Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements. The AAPS Journal 15:2, pages 483-497.
Crossref
Crossref
Arik Dahan, Avital Beig, Viktoriya Ioffe-Dahan, Riad Agbaria & Jonathan M Miller. (2012) The Twofold Advantage of the Amorphous Form as an Oral Drug Delivery Practice for Lipophilic Compounds: Increased Apparent Solubility and Drug Flux Through the Intestinal Membrane. The AAPS Journal 15:2, pages 347-353.
Crossref
Crossref
Aki T. Heikkinen, Stephen Fowler, Lynn Gray, Jia Li, Ying Peng, Preeti Yadava, Aruna Railkar & Neil Parrott. (2013) In Vitro to in Vivo Extrapolation and Physiologically Based Modeling of Cytochrome P450 Mediated Metabolism in Beagle Dog Gut Wall and Liver. Molecular Pharmaceutics 10:4, pages 1388-1399.
Crossref
Crossref
Sandra M. Gómez, Diana M. Cristancho & Fleming Martínez. (2013) Solubilization thermodynamics of ibuprofen in modified and classical FeSSIF biorelevant media. Journal of Molecular Liquids 179, pages 110-117.
Crossref
Crossref
Michael Gertz, Catherine M. Cartwright, Michael J. Hobbs, Kathryn E. Kenworthy, Malcolm Rowland, J. Brian Houston & Aleksandra Galetin. (2012) Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential. Pharmaceutical Research 30:3, pages 761-780.
Crossref
Crossref
Carl-Christer Johansson, Peter Gennemark, Per Artursson, Angela Äbelö, Michael Ashton & Rasmus Jansson-Löfmark. (2013) Population pharmacokinetic modeling and deconvolution of enantioselective absorption of eflornithine in the rat. Journal of Pharmacokinetics and Pharmacodynamics 40:1, pages 117-128.
Crossref
Crossref
Yurong Lai. 2013. Transporters in Drug Discovery and Development. Transporters in Drug Discovery and Development
633
674
.
M. D. Harwood, S. Neuhoff, G. L. Carlson, G. Warhurst & A. Rostami‐Hodjegan. (2012)
Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic
in vitro–in vivo
extrapolation of oral drug absorption
. Biopharmaceutics & Drug Disposition 34:1, pages 2-28.
Crossref
Crossref
Helena Anna Thörn, Erik Sjögren, Paul Alfred Dickinson & Hans Lennernäs. (2012)
Binding Processes Determine the Stereoselective Intestinal and Hepatic Extraction of Verapamil
in Vivo
. Molecular Pharmaceutics 9:11, pages 3034-3045.
Crossref
Crossref
Alexander V. LyubimovJasminder Sahi, Yurong Lai & Caroline Lee. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
51
.
Anne Sophie Grandvuinet, Henrik Tang Vestergaard, Nicolas Rapin & Bente Steffansen. (2012) Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug–drug interactions. Journal of Pharmacy and Pharmacology 64:11, pages 1523-1548.
Crossref
Crossref
Aki T. Heikkinen, Guillaume Baneyx, Antonello Caruso & Neil Parrott. (2012) Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates – An evaluation and case study using GastroPlus™. European Journal of Pharmaceutical Sciences 47:2, pages 375-386.
Crossref
Crossref
Kiyohiko Sugano. 2012. Biopharmaceutics Modeling and Simulations. Biopharmaceutics Modeling and Simulations
266
321
.
Kiyohiko Sugano. 2012. Biopharmaceutics Modeling and Simulations. Biopharmaceutics Modeling and Simulations
206
265
.
Kiyohiko Sugano. 2012. Biopharmaceutics Modeling and Simulations. Biopharmaceutics Modeling and Simulations
160
205
.
Kiyohiko Sugano. 2012. Biopharmaceutics Modeling and Simulations. Biopharmaceutics Modeling and Simulations
64
121
.
Arik Dahan, Hans Lennernäs & Gordon L. Amidon. (2012) The Fraction Dose Absorbed, in Humans, and High Jejunal Human Permeability Relationship. Molecular Pharmaceutics 9:6, pages 1847-1851.
Crossref
Crossref
Alex Avdeef. 2012. Absorption and Drug Development. Absorption and Drug Development
499
574
.
Alex Avdeef. 2012. Absorption and Drug Development. Absorption and Drug Development
319
498
.
Manthena V. Varma, Iain GardnerStefanus J. Steyn, Paul Nkansah, Charles J. Rotter, Carrie Whitney-Pickett, Hui Zhang, Li Di, Michael CramKatherine S. FennerAyman F. El-Kattan. (2012) pH-Dependent Solubility and Permeability Criteria for Provisional Biopharmaceutics Classification (BCS and BDDCS) in Early Drug Discovery. Molecular Pharmaceutics 9:5, pages 1199-1212.
Crossref
Crossref
Bilal S. Abuasal, Michael B. Bolger, Don K. WalkerAmal Kaddoumi. (2012)
In Silico
Modeling for the Nonlinear Absorption Kinetics of UK-343,664: A P-gp and CYP3A4 Substrate
. Molecular Pharmaceutics 9:3, pages 492-504.
Crossref
Crossref
Hyun Jung Kim, Dongeun Huh, Geraldine Hamilton & Donald E. Ingber. (2012) Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab on a Chip 12:12, pages 2165.
Crossref
Crossref
Leslie Z. Benet, Fabio Broccatelli & Tudor I. Oprea. (2011) BDDCS Applied to Over 900 Drugs. The AAPS Journal 13:4, pages 519-547.
Crossref
Crossref
E. Neirinckx, S. Croubels, S. De Boever, J.P. Remon, T. Bosmans, S. Daminet, P. De Backer & C. Vervaet. (2011) Species comparison of enantioselective oral bioavailability and pharmacokinetics of ketoprofen. Research in Veterinary Science 91:3, pages 415-421.
Crossref
Crossref
Kirstin Thelen, Katrin Coboeken, Stefan Willmann, Rolf Burghaus, Jennifer B. Dressman & Jörg Lippert. (2011) Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, Part 1: Oral solutions. Journal of Pharmaceutical Sciences 100:12, pages 5324-5345.
Crossref
Crossref
Matěj Velický, Kin Y. Tam & Robert A.W. Dryfe. (2011) In situ artificial membrane permeation assay under hydrodynamic control: Correlation between drug in vitro permeability and fraction absorbed in humans. European Journal of Pharmaceutical Sciences 44:3, pages 299-309.
Crossref
Crossref
Jacqueline Pusch, Miriam Votteler, Stella Göhler, Jasmin Engl, Martina Hampel, Heike Walles & Katja Schenke-Layland. (2011) The physiological performance of a three-dimensional model that mimics the microenvironment of the small intestine. Biomaterials 32:30, pages 7469-7478.
Crossref
Crossref
K S Amidon, P Langguth, H Lennernäs, L Yu & G L Amidon. (2011) Bioequivalence of Oral Products and the Biopharmaceutics Classification System: Science, Regulation, and Public Policy. Clinical Pharmacology & Therapeutics 90:3, pages 467-470.
Crossref
Crossref
Wei Zhu & Eun Ju Jeong. 2011. Oral Bioavailability. Oral Bioavailability
461
473
.
Mei-Ling Chen, Gordon L. Amidon, Leslie Z. Benet, Hans Lennernas & Lawrence X. Yu. (2011) The BCS, BDDCS, and Regulatory Guidances. Pharmaceutical Research 28:7, pages 1774-1778.
Crossref
Crossref
Helena Anna Thörn, Anna Lundahl, Johannes Antonius Schrickx, Paul Alfred Dickinson & Hans Lennernäs. (2011) Drug metabolism of CYP3A4, CYP2C9 and CYP2D6 substrates in pigs and humans. European Journal of Pharmaceutical Sciences 43:3, pages 89-98.
Crossref
Crossref
Arik Dahan, Yasuhiro Tsume, Jing Sun, Jonathan M. Miller & Gordon L. Amidon. 2011. Amino Acids, Peptides and Proteins in Organic Chemistry. Amino Acids, Peptides and Proteins in Organic Chemistry
277
292
.
Xinyuan Zhang, Robert A. Lionberger, Barbara M. Davit & Lawrence X. Yu. (2011) Utility of Physiologically Based Absorption Modeling in Implementing Quality by Design in Drug Development. The AAPS Journal 13:1, pages 59-71.
Crossref
Crossref
Paul A. Dawson. 2011. Drug Transporters. Drug Transporters
169
203
.
Nick Plant. 2011. Understanding the Dynamics of Biological Systems. Understanding the Dynamics of Biological Systems
59
82
.
Majid Y. Moridani. 2010. Prodrugs and Targeted Delivery. Prodrugs and Targeted Delivery
79
109
.
James M. Butler & Jennifer B. Dressman. (2010) The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development. Journal of Pharmaceutical Sciences 99:12, pages 4940-4954.
Crossref
Crossref
Kiyohiko Sugano. (2010) Aqueous Boundary Layers Related to Oral Absorption of a Drug: From Dissolution of a Drug to Carrier Mediated Transport and Intestinal Wall Metabolism. Molecular Pharmaceutics 7:5, pages 1362-1373.
Crossref
Crossref
Pilar Prieto, Sebastian Hoffmann, Valentina Tirelli, Francesco Tancredi, Isabel González, Marival Bermejo & Isabella De Angelis. (2010) An Exploratory Study of Two Caco-2 Cell Models for Oral Absorption: A Report on Their Within-laboratory and Between-laboratory Variability, and Their Predictive Capacity. Alternatives to Laboratory Animals 38:5, pages 367-386.
Crossref
Crossref
L Z Benet & C A Larregieu. (2010) The FDA Should Eliminate the Ambiguities in the Current BCS Biowaiver Guidance and Make Public the Drugs for Which BCS Biowaivers Have Been Granted. Clinical Pharmacology & Therapeutics 88:3, pages 405-407.
Crossref
Crossref
Jonathan M. Miller, Arik Dahan, Deepak Gupta, Sheeba Varghese & Gordon L. Amidon. (2010) Enabling the Intestinal Absorption of Highly Polar Antiviral Agents: Ion-Pair Facilitated Membrane Permeation of Zanamivir Heptyl Ester and Guanidino Oseltamivir. Molecular Pharmaceutics 7:4, pages 1223-1234.
Crossref
Crossref
Displaying 200 of 225 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list